{
  "name": "Johnson & Johnson",
  "slug": "johnson-and-johnson",
  "ticker": "JNJ",
  "fetched_at": "2025-11-16T12:20:51.910729+00:00",
  "news": [
    {
      "title": "Jim Cramer Praises Johnson & Johnson (JNJ)’s Drugs - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPaWVqQXRoZjRlYXBOS1lScFREUkdjWHJNYXZXMlV6M1JOM3dQakNleGxQVko2TzVSVTBna2FLNWhJel9GcEI3OHltak43RVdDS1FOU0pxdmpRSzM1dTJYQy1SSHFURnpYV1VVNnJVZGFkR3VaN3BzNG1NazBCcndJR2ZBY2JjdUk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPaWVqQXRoZjRlYXBOS1lScFREUkdjWHJNYXZXMlV6M1JOM3dQakNleGxQVko2TzVSVTBna2FLNWhJel9GcEI3OHltak43RVdDS1FOU0pxdmpRSzM1dTJYQy1SSHFURnpYV1VVNnJVZGFkR3VaN3BzNG1NazBCcndJR2ZBY2JjdUk?oc=5\" target=\"_blank\">Jim Cramer Praises Johnson & Johnson (JNJ)’s Drugs</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-13T16:36:11+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "BMS-J&J blood thinner fails phase 3, denting blockbuster hopes - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMirAFBVV95cUxON2dMUXFFSTl1M09NdFRVblNtMGg4LWJYNjBHSThKVEl0a2tOX1ZySm5lT1RQT1ZTMTdrSlpzd1ZzMzhnQV9qaWJCYVY5MzdpSTZhUnd2bTR0eVl0TkU5S3Y4bXhlRDMxV3hLazIyUFJTWHpUMDZ3YlUzUzhNa21qeW1abTBqeXFVRFBwOWdUT2RkMmN6R3Y3X2V2bGozb2luYnFWNUxkajZDcE1L?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirAFBVV95cUxON2dMUXFFSTl1M09NdFRVblNtMGg4LWJYNjBHSThKVEl0a2tOX1ZySm5lT1RQT1ZTMTdrSlpzd1ZzMzhnQV9qaWJCYVY5MzdpSTZhUnd2bTR0eVl0TkU5S3Y4bXhlRDMxV3hLazIyUFJTWHpUMDZ3YlUzUzhNa21qeW1abTBqeXFVRFBwOWdUT2RkMmN6R3Y3X2V2bGozb2luYnFWNUxkajZDcE1L?oc=5\" target=\"_blank\">BMS-J&amp;J blood thinner fails phase 3, denting blockbuster hopes</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-11-14T13:10:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Next-generation blood thinner from Bristol Myers Squibb, J&J fails key trial - statnews.com",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxNa2htQW5tekF5VWY2RDBNRW5fdHczRW9MN0huNk51dlVyMnRoWTJSVjlDREFoOEViSkZfZE9wYk9lV05teFhqVVYtRlBJWEhqMjdjNHhTU2V1VDNCMGR5M0tvd3lxOWdXbk9PZ0VCQ1VxcVhxeGJIdlZqNkptSWZjRkh1cmpnaHc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxNa2htQW5tekF5VWY2RDBNRW5fdHczRW9MN0huNk51dlVyMnRoWTJSVjlDREFoOEViSkZfZE9wYk9lV05teFhqVVYtRlBJWEhqMjdjNHhTU2V1VDNCMGR5M0tvd3lxOWdXbk9PZ0VCQ1VxcVhxeGJIdlZqNkptSWZjRkh1cmpnaHc?oc=5\" target=\"_blank\">Next-generation blood thinner from Bristol Myers Squibb, J&amp;J fails key trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font>",
      "published": "2025-11-14T13:05:24+00:00",
      "source": "statnews.com"
    },
    {
      "title": "Bristol Myers, J&J stop blood clotting drug trial after interim review - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQajVNbTV2MDUzd2FhM3c3MFktQWdRX2pQcVFPWmRwV3FBc0tpekljZHVJTzdScHVuazRiWGNnSWJVVVgwalRGWDdYSEtrb3J0MElyejlaR29tWWlWeHVsYmRaSlJUNVdqeTNwRjF1T1NuNjBzNUNMN1J0b0xqR1BqT3ZjMVdHbDZFN3BVTzVUMlRCTDNBT1NoYzVRU0NVWm5KSFZOb2Q4Z3QxNkJrdTQzV0dmQ0RFc0w4NHZtMTNJYWsxTXloeEVpX0N4Yw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxQajVNbTV2MDUzd2FhM3c3MFktQWdRX2pQcVFPWmRwV3FBc0tpekljZHVJTzdScHVuazRiWGNnSWJVVVgwalRGWDdYSEtrb3J0MElyejlaR29tWWlWeHVsYmRaSlJUNVdqeTNwRjF1T1NuNjBzNUNMN1J0b0xqR1BqT3ZjMVdHbDZFN3BVTzVUMlRCTDNBT1NoYzVRU0NVWm5KSFZOb2Q4Z3QxNkJrdTQzV0dmQ0RFc0w4NHZtMTNJYWsxTXloeEVpX0N4Yw?oc=5\" target=\"_blank\">Bristol Myers, J&amp;J stop blood clotting drug trial after interim review</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-11-14T16:53:25+00:00",
      "source": "Reuters"
    },
    {
      "title": "Johnson & Johnson Makes a Bold Move with CVRx Shares! - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxObW1idzVfcGJvMHg2Y2piclp0M1d3ZXBiLWZ1anllV3dGc1ZiUUdZSm9PM1dqZWljYzZGQnBrT0Z6N3N5dFFfZk5wRzA3djV5cmcxaWgwSDNVcWZlempEc0lTWEpJSXF6aE5CdVgyenVPQW9UZTF0a0VtSGREeEF0Tk96VjdBdTY0UjMxSmVmd1ZROE96aldRcjRFTFFpc29RdjU0WEtUVWcwWGVXeUo1THV3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxObW1idzVfcGJvMHg2Y2piclp0M1d3ZXBiLWZ1anllV3dGc1ZiUUdZSm9PM1dqZWljYzZGQnBrT0Z6N3N5dFFfZk5wRzA3djV5cmcxaWgwSDNVcWZlempEc0lTWEpJSXF6aE5CdVgyenVPQW9UZTF0a0VtSGREeEF0Tk96VjdBdTY0UjMxSmVmd1ZROE96aldRcjRFTFFpc29RdjU0WEtUVWcwWGVXeUo1THV3?oc=5\" target=\"_blank\">Johnson & Johnson Makes a Bold Move with CVRx Shares!</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-11-15T02:22:33+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Jim Cramer Notes Johnson & Johnson is “Really Bearing Down on High-Growth Pharma” - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihAFBVV95cUxOVXRId2hXWUhPcUdSanRscl83RWxJWUpLUFlwZU5fM0hiLVM2MDJGM2tMUE5lRXFNdzU2cDFZN3R3NVZYYkczRWY1czFBS3NyM3NKY3hDWUdlWUxlb1pCMlFnbXBRdUlKVWx3Z1VGcDlmZ3ZwczB4bmM0NldRYXRzOVpBcXU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihAFBVV95cUxOVXRId2hXWUhPcUdSanRscl83RWxJWUpLUFlwZU5fM0hiLVM2MDJGM2tMUE5lRXFNdzU2cDFZN3R3NVZYYkczRWY1czFBS3NyM3NKY3hDWUdlWUxlb1pCMlFnbXBRdUlKVWx3Z1VGcDlmZ3ZwczB4bmM0NldRYXRzOVpBcXU?oc=5\" target=\"_blank\">Jim Cramer Notes Johnson & Johnson is “Really Bearing Down on High-Growth Pharma”</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-13T17:09:41+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Johnson & Johnson (JNJ) Emerges as Scotiabank’s Top Pick for Curative Treatments - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxON2xndGp2WlN6LVZTcmNMLW9DNFY5Qmx1bndKVXdkRHV1MVRucmVGOFVuSDFqYVVRUHdrVFhFNkVQajhrTEd4Ny1EbVd4ZjRSTVB6blNJblkyTmxRZF9WeFA4N2NfMFZic05mS1BaYnY4Y3lrT1o5QjRnOFFEYjRhWGJ5MUtkaWVycm00Mg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxON2xndGp2WlN6LVZTcmNMLW9DNFY5Qmx1bndKVXdkRHV1MVRucmVGOFVuSDFqYVVRUHdrVFhFNkVQajhrTEd4Ny1EbVd4ZjRSTVB6blNJblkyTmxRZF9WeFA4N2NfMFZic05mS1BaYnY4Y3lrT1o5QjRnOFFEYjRhWGJ5MUtkaWVycm00Mg?oc=5\" target=\"_blank\">Johnson & Johnson (JNJ) Emerges as Scotiabank’s Top Pick for Curative Treatments</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-16T03:01:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Merck pays $9.2B for Cidara, picking up flu antiviral spurned by J&J - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPTm5acXRwN0JLTEpCR3RVTjR3Q3pwdExza0szTFpSSTdIR0RJM29qN05PenRoNUZWRGtGVVFjbDdVVERXME9TX0s2cUZMb2hKWEExaHBMcUxJdW1zaEV6bVA4UVUzV29QSndNeVNab2NDQVFDMnJXRlhoZzVnQmRQZFNFVGN6MjhSU1ZIaTgyYWtZSWNPREo3aHhYMzVDZzQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxPTm5acXRwN0JLTEpCR3RVTjR3Q3pwdExza0szTFpSSTdIR0RJM29qN05PenRoNUZWRGtGVVFjbDdVVERXME9TX0s2cUZMb2hKWEExaHBMcUxJdW1zaEV6bVA4UVUzV29QSndNeVNab2NDQVFDMnJXRlhoZzVnQmRQZFNFVGN6MjhSU1ZIaTgyYWtZSWNPREo3aHhYMzVDZzQ?oc=5\" target=\"_blank\">Merck pays $9.2B for Cidara, picking up flu antiviral spurned by J&amp;J</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-11-14T13:25:00+00:00",
      "source": "Fierce Biotech"
    }
  ],
  "product_launches": [
    {
      "title": "Is Johnson & Johnson’s Recent 35% Surge Justified by Its 2025 Valuation? - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Is Johnson & Johnson’s Recent 35% Surge Justified by Its 2025 Valuation?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-13T16:53:56+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Johnson & Johnson launches daily disposable multifocal toric contact lens - MassDevice",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQUlhsdVdjcDl4bGdLQmdaS0lTNnpWS21CM2F6ZUhNUmRreGU2bUt2UVVfZlE5QllWZ1pxdml6ZjdXWnczeHROQ3J2R3p4YmJGQXhuYkNfZHNXNDQtaXppSEp3cXRyZjRobjREbUh4VDhKUVNzVGhsZXUzaW42em1LRzdnc0VFOVVLZ1lSV1pLdmlucnRCdFVPUF9EekJoMDBK?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxQUlhsdVdjcDl4bGdLQmdaS0lTNnpWS21CM2F6ZUhNUmRreGU2bUt2UVVfZlE5QllWZ1pxdml6ZjdXWnczeHROQ3J2R3p4YmJGQXhuYkNfZHNXNDQtaXppSEp3cXRyZjRobjREbUh4VDhKUVNzVGhsZXUzaW42em1LRzdnc0VFOVVLZ1lSV1pLdmlucnRCdFVPUF9EekJoMDBK?oc=5\" target=\"_blank\">Johnson & Johnson launches daily disposable multifocal toric contact lens</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MassDevice</font>",
      "published": "2025-06-23T07:00:00+00:00",
      "source": "MassDevice"
    },
    {
      "title": "Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMinAJBVV95cUxNVTk1X25qaHJuQURPZktUYmJQQ3pLTlZqaHJRWjdjcVBfRnRaUVB1UnROekN4aU14ek5DQW5oOW51dmt1M0hTR2tXMG9hMDlzeEVscDNfVWs1cmF4eXlkY1BtVzM0NGtjZVNnSmxwX3Z3X2FHc0haZVJaM1lHWmlwMEpnVkxIalI4LUZ1alNyUlp6emY5b1NCV214WVlBam01QjFNQlFYeTZWOFZLVmpHOFN5LTFsQlVETVZXQWRiVEhZWUdiaFJ6SFNqSTBuMEZKTWptRE5zNUJLNVc4TjFXZWI4WlVOT2hTc1BvZE51S1NmRzR6RHd1YUNkQThwRlJfS0hIcER5dURkYUlOQ1FnTW5fMmVDUUFiSmlYcA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAJBVV95cUxNVTk1X25qaHJuQURPZktUYmJQQ3pLTlZqaHJRWjdjcVBfRnRaUVB1UnROekN4aU14ek5DQW5oOW51dmt1M0hTR2tXMG9hMDlzeEVscDNfVWs1cmF4eXlkY1BtVzM0NGtjZVNnSmxwX3Z3X2FHc0haZVJaM1lHWmlwMEpnVkxIalI4LUZ1alNyUlp6emY5b1NCV214WVlBam01QjFNQlFYeTZWOFZLVmpHOFN5LTFsQlVETVZXQWRiVEhZWUdiaFJ6SFNqSTBuMEZKTWptRE5zNUJLNVc4TjFXZWI4WlVOT2hTc1BvZE51S1NmRzR6RHd1YUNkQThwRlJfS0hIcER5dURkYUlOQ1FnTW5fMmVDUUFiSmlYcA?oc=5\" target=\"_blank\">Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-07-29T07:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "J&J launches Acuvue Oasys Max 1-Day MF contact lens for astigmatism - Eyes On Eyecare",
      "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOWTNPemRKcGRQTVFfUUZUblJ4RDlGYzhtMmpGSjlfUk0xVC1YdFhEQjd3bm44ZGR2UXF0LVFIaDRhNDZ0RTNiLW11MklEb21yc1NFWkdyODBqNklYQ1hxNmJXVGpRd0VnTUpsYnNmcEIzZmV4QjhpVFl3TmtxSFAwMUhZWVp4MTBoOHlvR3RoU2RiTGpOcmJ2WG50djQ2UFVVdF96QU1JbGpRcWZXUURkTTQ4ZE1HcDQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxOWTNPemRKcGRQTVFfUUZUblJ4RDlGYzhtMmpGSjlfUk0xVC1YdFhEQjd3bm44ZGR2UXF0LVFIaDRhNDZ0RTNiLW11MklEb21yc1NFWkdyODBqNklYQ1hxNmJXVGpRd0VnTUpsYnNmcEIzZmV4QjhpVFl3TmtxSFAwMUhZWVp4MTBoOHlvR3RoU2RiTGpOcmJ2WG50djQ2UFVVdF96QU1JbGpRcWZXUURkTTQ4ZE1HcDQ?oc=5\" target=\"_blank\">J&amp;J launches Acuvue Oasys Max 1-Day MF contact lens for astigmatism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Eyes On Eyecare</font>",
      "published": "2025-06-24T07:00:00+00:00",
      "source": "Eyes On Eyecare"
    },
    {
      "title": "Johnson & Johnson Kicks Off 'Powerful New Product Cycle': Analyst - Johnson & Johnson (NYSE:JNJ) - Benzinga",
      "link": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxOQTFyVGpMbjFLSUJ0TzFDTkRrbXlnQWh0TDYyNjBVM2htMDFoRHNhTWRoWWhWeWR6bTZYVjVrWnlCdkl4LTNUek9PRU5oXzZyUlJQaVVlMzAtSDFBajdleFBhTTVzc3k4bVE3MVlGb3JpU0dPX1Y2ZklDMHR1WlpLWUFQTndKa2NXQ2UtTkRZYVN1bV91V0E5MjFhYllqYk5iSy16RHNWd2w0MHhKOHNNY3lBb0pNaDBxNWhkTjF5b3dkTVlrQldtZ1l2SG5wTXBKN0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOQTFyVGpMbjFLSUJ0TzFDTkRrbXlnQWh0TDYyNjBVM2htMDFoRHNhTWRoWWhWeWR6bTZYVjVrWnlCdkl4LTNUek9PRU5oXzZyUlJQaVVlMzAtSDFBajdleFBhTTVzc3k4bVE3MVlGb3JpU0dPX1Y2ZklDMHR1WlpLWUFQTndKa2NXQ2UtTkRZYVN1bV91V0E5MjFhYllqYk5iSy16RHNWd2w0MHhKOHNNY3lBb0pNaDBxNWhkTjF5b3dkTVlrQldtZ1l2SG5wTXBKN0E?oc=5\" target=\"_blank\">Johnson & Johnson Kicks Off 'Powerful New Product Cycle': Analyst - Johnson & Johnson (NYSE:JNJ)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "Benzinga"
    }
  ],
  "stock": {
    "ticker": "JNJ",
    "currency": "USD",
    "latest": {
      "date": "2025-11-14",
      "close": 195.92999267578125
    },
    "history": [
      {
        "date": "2025-11-06",
        "close": 186.97000122070312
      },
      {
        "date": "2025-11-07",
        "close": 186.57000732421875
      },
      {
        "date": "2025-11-10",
        "close": 188.41000366210938
      },
      {
        "date": "2025-11-11",
        "close": 193.8300018310547
      },
      {
        "date": "2025-11-12",
        "close": 194.38999938964844
      },
      {
        "date": "2025-11-13",
        "close": 195.25
      },
      {
        "date": "2025-11-14",
        "close": 195.92999267578125
      }
    ],
    "name": "Johnson & Johnson"
  }
}